Why the study?
Does procainamide induce serologic changes in asymptomatic cardiac patients compared to quinidine or controls?
Does procainamide induce serologic changes in asymptomatic cardiac patients compared to quinidine or controls?
Procainamide therapy for 6 weeks or more frequently induces autoantibodies (LE cells, anti-DNP, anti-DNA) even in asymptomatic cardiac patients.
Answers are grounded in this paper and cite their sources.
Procainamide was associated with frequent autoantibody induction in asymptomatic patients; leaves open clinical significance and need for prospective monitoring studies.
Serologic findings in cardiac patients who had no manifestations of drug‐induced lupus and who had been taking procainamide for 6 weeks or more were compared to a similar group receiving quinidine, and a series of age‐ and sex‐matched controls. Significant changes occurred only in the group of 22 patients treated with procainamide (p < 0.01). LE cell tests were positive in 12 (55 per cent). Antidesoxyribonucleoprotein (anti‐DNP) tests were positive in 15 (68 per cent) and anti‐DNA in 8 (36 per cent). A positive LE cell test, anti‐DNP, or anti‐DNA reaction was found in 17 (77 per cent).
No takes yet. Share an insight, caveat, or question.
Molina et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: